CSL Limited

CSL Limited

CSL Limited

Overview
Date Founded

1991

Headquarters

45 Poplar Road, Parkville, VIC, 3052, AUS

Type of Company

Public

Employees (Worldwide)

27K

Industries

Biotechnology
IT Consulting & Services
Hospitals & Patient Services
Medical Support Services
Pharmaceuticals

Company Description

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.

Contact Data
Trying to get in touch with decision makers at CSL Limited? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer, Executive Director & MD

Chief Scientific Officer & Executive Director

Chief Financial Officer

Chief Operating Officer

Executive Vice President Legal & Group General Counsel

Executive Vice President & Chief Commercial Officer

President, Seqirus

Executive Vice President, Quality & Business Services

Executive Vice President-Strategy & Business Development

Chief Executive Officer

Paths to CSL Limited
Potential Connections via
Relationship Science
You
CSL Limited
Owners & Shareholders
Details Hidden

BlackRock IM-Australia employs a disciplined process and analytical tools to construct portfolios from a variety of investment products across asset classes, market-caps, styles and geographies. Their enhanced-passive investment style is based mainly on an indexed approach and permits a large number of small, active stock positions in the portfolio, seeking to add value above the benchmark. The firm manages fixed-income portfolios with exposure to global bonds as well as bond portfolios denominated in various currencies. They partner with the BlackRock Solutions team to ensure standardized metrics for consistently assessing and managing risk in line with their clients' objectives.

Details Hidden

WCM employs a bottom-up, fundamental method of analysis that emphasizes long-horizon growth prospects, competitive advantages, and company cultures conducive to attracting great people. Valuation also plays an important factor in the firm’s analysis method, predominantly impacting the timing of decisions and portfolio position sizing. Their strategies utilize different capitalization ranges (e.g., large-cap, small-cap, all-cap,) different geographical scopes (e.g., international, global, emerging markets, US domestic) and different security types (e.g., foreign ordinary shares, ADR). WCM’s Investment Strategy Group (ISG), consisting of senior investment professionals, makes all portfolio decisions.

Details Hidden

FSIHK manages client accounts and funds that invest predominantly across Asian (including China and Japan) and Global Emerging Market equities: a focus on quality companies, considering risk with an absolute mind set, adopting a long-term time horizon with a keen eye to reasonably priced growth prospects. The firm is an active manager which begins their investment process by identifying companies that are growing earnings per share and where they believe the market has incorrectly priced their future growth potential.

Recent Transactions
Details Hidden

CSL Behring LLC, CSL Limited purchase Vitaeris, Inc.

Details Hidden

CSL Limited purchases Guangzhou Junxin Pharmaceutical Ltd.

Details Hidden

CSL Limited, CSL Behring Asia Pacific Ltd. purchase Wuhan Zhongyuan Ruide Biological Products Co., Ltd. from Humanwell Healthcare (Group) Co., Ltd.

Transaction Advisors
Investment Advisor

Advised onCSL Limited purchases Zlb Bio Plasma AG from Rotkreuzstiftung Zentrallaboratorium Blutspendedientst SRK

Accountant

Advised onCSL Limited, Zlb Bio Plasma AG purchase Nabi, Inc. /Antibody Collection Business from Nabi Biopharmaceuticals

Investment Advisor

Advised onCSL Limited, CSL Behring Asia Pacific Ltd. purchase Wuhan Zhongyuan Ruide Biological Products Co., Ltd. from Humanwell Healthcare (Group) Co., Ltd.

Associate

Advised onCSL Limited, CSL Behring LLC purchase Calimmune, Inc. from TVP Management Co. LLC, Alexandria Venture Investments LLC, AbbVie Biotech Ventures, Inc.

Advisors & Consultants
Legal Advisor

Partner at Weil, Gotshal & Manges LLP

Advisor

Partner at Centerview Partners LLC

Legal Advisor

Partner at Simpson Thacher & Bartlett LLP

Clients

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on 2013 and is headquartered in North Chicago, IL.

The Government of the Commonwealth of Australia (also referred to as the Australian Government, the Commonwealth Government, or the Federal Government) is the government of the Commonwealth of Australia, a federal parliamentary constitutional monarchy.

Valneva SE is a biotech company. The firm engages in the development, production and marketing of vaccine and preventive medicine. It operates through the following segments: Commercialized Vaccines, Technologies and Services and Vaccine Candidates. The Commercialized Vaccines segment includes currently marketed vaccines of the group such as JEV and DUKORAL. The Technologies and Services segment regroups services and inventions in commercialization stage. The Vaccine Candidates segment consists of proprietary research and development programs aiming to generate new approvable products. The company was founded on April 7, 1999 and is headquartered in Saint-Herblain, France.

Key Stats and Financials As of 2020
Market Capitalization
$101B
Total Enterprise Value
$94.8B
Earnings Per Share
$4.76
EBITDAMargin
33.91%
Enterprise Value / Sales
10.15x
Enterprise Value EBITDAOperating
29.92x
TEVNet Income
43.91x
Debt TEV
0.06x
Three Year Compounded Annual Growth Rate Of Revenue
13.93%
Revenue
$9.35B
Net Profit
$2.16B
EBITDA
$3.17B
Total Debt
$5.99B
Total Equity
$6.53B
Investors
Details Hidden

Co-Founder at Motability

Suppliers
Brandywine Realty Trust Trusts & Funds | Philadelphia, Pennsylvania

Brandywine Realty Trust is a real estate investment trust, which engages in owning, leasing, and managing an urban, town centre and suburban office portfolio. Its services include asset management, development and construction, investment, marketing & leasing, property management and tenant. The firm operates through the following business segments: Philadelphia Central Business District, Pennsylvania Suburbs, Metropolitan Washington, Austin & Texas and Other. The Philadelphia Central Business District segment includes properties located in the city of Philadelphia, Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware, and Montgomery counties in the Philadelphia suburbs. The Metropolitan Washington D.C Segment includes properties in the district of Columbia, Northern Virginia and southern Maryland. The Austin, Texas segment includes properties in the City of Austin, Texas. The Other segment includes properties located in Camden County in New Jersey and properties in New Castle County in Delaware. The company was founded by Gerard H. Sweeney in 1986 and is headquartered in Philadelphia, PA.

Cumberland Pharmaceuticals, Inc. Biotechnology | Nashville, Tennessee

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its product include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, and RediTrex. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.

BioCryst Pharmaceuticals, Inc. Medical Support Services | Birmingham, Alabama

Founded in 1986, BioCryst has approximately 38 employees between the Company’s headquarters in Durham, North Carolina and its Discovery Center of Excellence in Birmingham, Alabama. With expertise in drug discovery, clinical development and regulatory affairs, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. We are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. The commitment of BioCryst has remained unchanged. We continue to be passionate about advancing novel therapeutics for patients with serious diseases.

Awards & Honors
Rank #32
2011
Forbes Magazine - The Nifty 50
Sponsored by
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by CSL Limited. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of CSL Limited's profile does not indicate a business or promotional relationship of any kind between RelSci and CSL Limited.